Well before the latest government shutdown, the U.S. Department of Justice’s National Security Division (DOJ NSD) issued a final rule at 28 CFR Part 202 (“2025 Final Rule” or “Rule”) to help prevent ...
Ollin Biosciences Announces Final Data From Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema OLN324 ...
Prophylactic treatment for hemophilia B necessitates lifelong, regular intravenous factor IX infusions. Gene therapy offers the possibility of a single-dose treatment that produces durable endogenous ...
Hosted on MSN
Novartis reports final data of ALIGN trial in IgAN
Novartis has announced final data from the Phase III ALIGN study, highlighting that Vanrafia (atrasentan) slowed kidney function decline in adults with immunoglobulin A nephropathy (IgAN). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results